Sonoma Pharmaceuticals
Stock Forecast, Prediction & Price Target

Sonoma Pharmaceuticals Financial Estimates

Sonoma Pharmaceuticals Revenue Estimates

Sonoma Pharmaceuticals EBITDA Estimates

Sonoma Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2022 3/31/2023 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
$12.62M
 
N/A
$13.27M
 
5.09%
$12.73M
 
-4.04%
Avg: $21.27M
Low: $21.27M
High: $21.27M
avg. 67.02%
Avg: $22.1M
Low: $22.1M
High: $22.1M
avg. 3.89%
Net Income
 
% change YoY
$-5.08M
 
N/A
$-5.15M
 
-1.27%
$-4.83M
 
6.13%
Avg: $-818.1K
Low: $-818.1K
High: $-818.1K
avg. 83.07%
Avg: $-1.18M
Low: $-1.18M
High: $-1.18M
avg. -44.44%
EBITDA
 
% change YoY
$-6.57M
 
N/A
$-4.44M
 
32.38%
$-4.52M
 
-1.79%
Avg: $-7.38M
Low: $-7.38M
High: $-7.38M
avg. -63.14%
Avg: $-7.67M
Low: $-7.67M
High: $-7.67M
avg. -3.89%
EPS
 
% change YoY
-$1.92
 
N/A
-$30.4
 
-1483.33%
-$10.64
 
64.99%
Avg: -$0.09
Low: -$0.09
High: -$0.09
avg. 99.15%
Avg: -$0.13
Low: -$0.13
High: -$0.13
avg. -44.44%
Operating Expenses
 
% change YoY
$9.88M
 
N/A
$9.04M
 
-8.43%
$9.44M
 
4.41%
Avg: $13.87M
Low: $13.87M
High: $13.87M
avg. 46.92%
Avg: $14.42M
Low: $14.42M
High: $14.42M
avg. 3.89%

FAQ

What is Sonoma Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 19.31% in 2026-2027.

We have gathered data from 1 analysts. Their low estimate is -818.1K, average is -818.1K and high is -818.1K.

What is Sonoma Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 35.46% in 2026-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $21.27M, average is $21.27M and high is $21.27M.

What is Sonoma Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 27.35% in 2026-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.09, average is -$0.09 and high is $-0.09.